carvedilol
Selected indexed studies
- Carvedilol sensitizes chemotherapy by targeting STING to boost anti-tumor immunity. (Cell Rep, 2025) [PMID:40249703]
- Carvedilol. (Profiles Drug Subst Excip Relat Methodol, 2013) [PMID:23668404]
- Carvedilol and traditional nonselective beta blockers for the secondary prophylaxis of variceal hemorrhage and portal hypertension related complications among patients with decompensated cirrhosis: a systematic review and network meta-analysis. (Hepatol Int, 2025) [PMID:40178720]
_Worker-drafted node — pending editorial review._
Connections
carvedilol is a side effect of
Sources
- Carvedilol and bisoprolol as initial therapy for adult hypertension without compelling indications. (2019) pubmed
- Carvedilol sensitizes chemotherapy by targeting STING to boost anti-tumor immunity. (2025) pubmed
- Carvedilol. (2013) pubmed
- Carvedilol and traditional nonselective beta blockers for the secondary prophylaxis of variceal hemorrhage and portal hypertension related complications among patients with decompensated cirrhosis: a systematic review and network meta-analysis. (2025) pubmed
- Mechanistic insights into carvedilol's potential protection against doxorubicin-induced cardiotoxicity. (2024) pubmed
- Is Carvedilol Effective in Preventing and Modulating Concentric Cardiac Remodelling? A Comprehensive Systematic Review and Meta-Analyses. (2025) pubmed
- The pharmacology of carvedilol. (1990) pubmed
- How Carvedilol activates β(2)-adrenoceptors. (2022) pubmed
- Carvedilol for hypertension. (1995) pubmed
- Carvedilol: a review of its use in chronic heart failure. (2003) pubmed